Lipoprotein(a) and Oxidized Phospholipids Independent Risk Factors for Cardiovascular Disease Dr. Mahalakshmi Sivashankaran11 May 2023 2:30 PM GMTUSA: A new study published in the Journal of the American College of Cardiology has found that lipoprotein(a) (Lp[a]) and oxidized phospholipids...
Tirzepatide Slows CKD Progression among diabetes patients with Increased CV risk Dr. Kamal Kant Kohli7 Jun 2022 3:45 AM GMTTirzepatide can slow progression of chronic kidney disease in type 2 diabetes according to an analysis of SURPASS-4 data presented at ADA 2022. In...
Aprocitentan found efficacious in patients with resistant hypertension in Phase 3 study Dr. Kamal Kant Kohli26 May 2022 2:15 PM GMTAprocitentan is an investigational, oral, dual endothelin receptor antagonist designed to potently inhibit the binding of endothelin-1 (ET-1) to ETA...
Thyroid hormone treatment connected to cardiovascular mortality Dr. Nandita Mohan19 May 2022 4:45 AM GMTIn a population-based cohort study of 705 307 adults who received thyroid hormone treatment, 10.8% died of cardiovascular causes. Both exogenous...
Cholesterol lowering drugs for high heart risk patients must be added Dr. Nandita Mohan16 May 2022 5:30 AM GMTA panel of international experts and patients in The BMJ said that additional cholesterol- lowering drugs should be offered to patients with high...
Reduction of CV events by PCSK9 inhibitors and ezetimibe: Clinical practice guideline Dr. Kamal Kant Kohli13 May 2022 4:00 AM GMTAdditional cholesterol lowering drugs should be offered to patients with high levels of 'bad' (LDL) cholesterol (70 mg/dl or higher) who are also at...
SGLT2 Inhibitors Reduce Hyperkalemia in High-Risk T2DM Patients MD Bureau3 May 2022 4:30 AM GMTHyperkalemia can occur in people with type 2 diabetes, especially in those with chronic kidney disease (CKD), and is clinically important because it...
CAC score provides modest gain in CVD risk assessment at expense of increasing cost: JAMA Medha Baranwal28 April 2022 4:30 AM GMTAustralia: A study determining the incremental gain from coronary artery calcium score (CACS) addition to a standard cardiovascular disease (CVD) risk...
Implantable heart monitor doesn't benefit heart attack survivors overall Dr. Kamal Kant Kohli13 April 2022 3:30 AM GMTPatients who received an implantable heart rhythm monitor after suffering a heart attack did not have fewer subsequent cardiovascular events overall,...
Exercise associated with decreased stress associated neural activity Dr Priyanka Ahuja7 April 2022 12:30 PM GMTA recent study found that exercise is associated with dose-dependent increases in mPFC activity. This effect does not directly reduce MACE risk;...
Tools for helping cardiovascular risk among adults with serious mental illness Dr. Nandita Mohan24 March 2022 1:30 PM GMTClinical decision support (CDS) tools are typically technology-based interventions that provide patient-specific information, often at the point of...
Cocoa flavanol supplementation may reduce risk of cardiovascular disease Hina Zahid18 March 2022 6:00 AM GMTLong term supplementation of cocoa flavanols may prevent cardiovascular disease, finds first large-scale trial.In papers published in The American...
